Innate Pharma SA (IPHA:NASDAQ)

$1.6 0.02 (1.27%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 55

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed Innate Pharma SA (IPHA:NASDAQ) News Sources

ImmunityBio, Inc. (IBRX) Q4 2025 Earnings Call Transcript

Seeking Alpha

external link

Glenmark Pharmaceuticals wins USFDA nod for fluticasone inhaler

The Economic Times

external link

Sana Biotechnology, Inc. (SANA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Seeking Alpha

external link

Sanofi Receives Orphan Drug Designation in Japan for Rilzabrutinib to Treat IgG4 Related Disease

EuropaWire

external link
IPHA stock
IPHA stock price
IPHA stock price today
IPHA stock prediction
IPHA earnings date
IPHA news
IPHA price
IPHA share
IPHA share price
IPHA shares
IPHA ceo
IPHA premarket
$IPHA
IPHA ticker
IPHA after hours
IPHA stock
IPHA stock price
IPHA stock price today
IPHA stock prediction
IPHA earnings date
IPHA news
IPHA price
IPHA share
IPHA share price
IPHA shares
IPHA ceo
IPHA premarket
$IPHA
IPHA ticker
IPHA after hours

Innate Pharma SA (IPHA:NASDAQ) FAQs

toggle

What is the current price of Innate Pharma SA (IPHA:NASDAQ)?

The current price of Innate Pharma SA (IPHA:NASDAQ) is $1.6.


toggle

Innate Pharma SA (IPHA:NASDAQ) absolute price change since previous trading day?

The absolute price change of Innate Pharma SA (IPHA:NASDAQ) since the previous trading day is $0.02.


toggle

Innate Pharma SA (IPHA:NASDAQ) percentage price change since previous trading day?

The percentage price change of Innate Pharma SA (IPHA:NASDAQ) since the previous trading day is 1.27%.


toggle

What is This Week's average sentiment score for Innate Pharma SA (IPHA:NASDAQ)?

This Week's average sentiment score for Innate Pharma SA (IPHA:NASDAQ) is 55 out of 100.


toggle

What is This Week's average sentiment for Innate Pharma SA (IPHA:NASDAQ)?

This Week's sentiment for Innate Pharma SA (IPHA:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.